Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 325 of 1,261
  1. US 11077108

    Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition

    The Regents of the University of California · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  2. US 11077079

    GHB formulation and method for its manufacture

    Jazz Pharmaceuticals Ireland Limited · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  3. US 11077078

    Compositions and methods for the treatment of cancer

    KoDiscovery, LLC · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  4. US 11077072

    Binge behavior regulators

    CLEARMIND MEDICINE INC. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  5. US 11078170

    Cyclic sulfamide compounds and methods of using same

    ASSEMBLY BIOSCIENCES, INC. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  6. US 11077101

    Compounds and methods of use

    Tango Therapeutics, Inc. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  7. US 11077090

    Compounds and compositions and uses thereof

    PGI Drug Discovery LLC · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  8. US 11077068

    Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions

    Aquestive Therapeutics, Inc. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  9. US 11076599

    Antimicrobial coating comprising chalcogenide nano-particles capped by chitosan

    The Board of Regents of the University of Texas System · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  10. US 11077057

    Polymer-grafted nanobins

    Northwestern University · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  11. US 11079379

    Methods of treating transthyretin (TTR) mediated amyloidosis

    Alnylam Pharmaceuticals, Inc. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  12. US 11078485

    Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

    Ionis Pharmaceuticals, Inc. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  13. US 11078471

    Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)

    Northwestern University · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  14. US 11078289

    Cancer treatment

    VANDA PHARMACEUTICALS INC. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  15. US 11078298

    Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods

    BANYAN BIOMARKERS, INC. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  16. US 11078264

    Inhibiting granulocyte macrophage-colony stimulating factor (GM-CSF) prevents preterm birth

    UNIVERSITY OF CONNECTICUT · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  17. US 11078257

    Recombinant gram negative bacteria and methods of generating and utilizing same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  18. US 11078486

    Compounds and methods for reducing ATXN2 expression

    Ionis Pharmaceuticals, Inc. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  19. US 11078250

    High-activity long-acting hypoglycemic fusion protein as well as preparation method and medical application thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  20. US 11078256

    Methods and compositions for inhibiting cancer cell growth

    The Board of Regents of the University of Texas System · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  21. US 11078242

    Peptides for Covid-19 prevention and treatment

    SOTIRA COVID, LLC · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  22. US 11078227

    5′-cyclo-phosphonate modified nucleotides

    Arrowhead Pharmaceuticals, Inc. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  23. US 11078239

    Prefusion PIV F immunogens and their use

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  24. CA 3162611

    COMPLEXES DE FER ET SELS DE CEUX-CI UTILISES EN TANT QU'AGENTS DE CONTRASTE POUR IRM

    BRACCO IMAGING SPA [IT] · Granted Jul 29, 2021 · Expires Jul 24, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.